Sirona Biochem Corp V.SBM

This sounds pretty good to me

[tylerreddick]

" We are especially excited about Sirona Biochem’s GlycoProteMim which operates on a fundamentally different principle than its predecessors. While Retinoids work by promoting cell turnover and collagen production, and dermal fillers and toxins mainly provide volume and temporarily paralyze facial muscles, GlycoProteMim offers a multifaceted approach. It not only targets the surface-level appearance but also addresses the underlying cellular mechanisms that contribute to skin aging. It acts as a true rejuvenation treatment, restoring cells and their functions to their original youthful state before the deleterious effects of age.

Moreover, the development of GlycoProteMim is a testament to the broader trend of leveraging biotechnology and biomimetics in skincare. Researchers are increasingly looking to nature and the body's natural processes for inspiration, creating compounds that work in harmony with the skin’s physiology rather than against it. This not only enhances efficacy but also reduces potential side effects, making treatments safer for a broader range of individuals. GlycoProteMim is a biomimicry of glycoproteins found in Antartic fish that protect them from harsh environmental stressors including nutrient deprevation and oxidative stress. "

[tylerreddick]

" Novel Topicals like OneSkin, GlycoProteMim™ and Pitera™, will gain traction for their unique, scientifically-backed benefits. These novel topicals offer multi-faceted skin benefits — from deep hydration and cellular renewal to robust protection against environmental stressors — without the aggressive side effects often linked to retinoids. As consumers become more knowledgeable and

[tylerreddick]

" In the quest to combat age-related skin concerns, we believe two groundbreaking topical agents, Pitera™ and GlycoProteMim™, will emerge as potential frontrunners. Both Pitera™ and GlycoProteMim™ represent significant strides in the field of dermatology, offering promising solutions to age-related skin issues. Pitera™, with its nutrient-rich profile, enhances skin vitality and youthfulness

[MirrorWorldMan]

Smokescreen to distract from AbbVie deal which is considered dead, or we would be trading higher. See it all the time with micro cap biotechs.  Issue fodder of future pipeline breakthroughs to cover up past and current failures. 

[Pandora]

Maybe AbbVie bought it just for that express thought of putting it on the shelf for a considerable period of time. Keep it out of the market while they market something else. Why not a conspiracy theory thrown in? :-))

[Fruckedagain]

How about this for a conspiracy theaory? The science is just no good. 

[Pareto8020]

That's why third party clinical trials are done so I'm confident the science is solid. Management on the other hand is the opposite of solid.

[lscfa]

From: Michelle Seltenrich Date: October 6, 2022 at 12:10:20PM MDT To: xxxxxxxx Subject: RE: Non-disclosure is Sirona's choice   "Abbvie is not obligated to commercial the 1067 tech.    Abbvie is not obligated to proceed in a timely manner.  Sirona has no recourse if Abbvie does not act.   Recall how long Wanbang took and

[Fruckedagain]

They are sure buying a lot of stock....but then maybe they aren't because they don't want to lose the money they are being paid. Why be stupid? Time for the head donkey to put out a new donkeyupdate for us shareholder donkeys. Where is that rascal bioruns? i miss him.